Center for Colon Cancer Research

结肠癌研究中心

基本信息

项目摘要

DESCRIPTION (provided by applicant): This Phase III COBRE application seeks to support and sustain the momentum achieved during developmental Phases I and II of the Center for Colon Cancer Research (CCCR) at the University of South Carolina. In the US and South Carolina, colorectal cancer remains the 2nd leading cause of cancer death and the 4th highest in incidence. In the 91/2 years since COBRE funding was initiated, the CCCR has made significant strides in enhancing the critical mass of independent scientists studying this disease, as judged by establishment of fully functional laboratories, receipt of extramural research grants, and publication in highly regarded, peer-reviewed journals. In addition, a vibrant outreach program has been designed and implemented to educate citizens from diverse economic backgrounds about colorectal cancer and the value of screening, making South Carolina a national leader in advocacy for this disease. The CCCR is now a fully established, self-standing center that contributes to the nation's goal of reducing the morbidity of colorectal cancer. To carry on with this effort, the CCCR will implement the following aims during Phase III: Provision of administrative services and support through the Administrative Core. Support of financial, programmatic, and training aspects of the CCCR research and outreach effort will be provided. Operation of a group of interactive Research Cores. CCCR investigators will have state-of-the-art expertise and technology available through four Cores, each of which is led by an experienced and knowledgeable member of the CCCR faculty. Oversight of a Research Pilot Project Program. Through fiscal support for development of investigator initiated seed projects, as well as development of multi-disciplinary programs, the Pilot Project effort will enable entry into challenging new research areas, and will mediate unique collaborations. In addition, the project will manage a graduate scholarship program for underserved minorities. In all, the wide range of knowledge and proficiency exhibited by the interdisciplinary faculty comprising the CCCR provides the basis for sustaining, during Phase III period, that which was built during Phases I and II.
描述(由申请人提供):本III阶段的申请旨在支持和维持南卡罗来纳大学结肠癌研究中心(CCCR)的发育阶段I和II期间所取得的势头。在美国和南卡罗来纳州,大肠癌仍然是癌症死亡的第二大原因,发病率是第四高。自从圆锥筹资金开始以来的91/2年中,CCCR在增强研究这种疾病的独立科学家的关键质量方面取得了长足的进步,这是根据建立功能齐全的实验室,收到壁外研究补助的判断,并在受到高度关注的,同行评审的期刊上发表。此外,已经设计和实施了一项充满活力的外展计划,以教育来自多种经济背景的公民有关结直肠癌和筛查的价值,使南卡罗来纳州成为这种疾病倡导的国家领导者。 CCCR现在是一个完全建立的,独立的中心,有助于该国降低结直肠癌的发病率的目标。为了继续这项工作,CCCR将在第三阶段实施以下目标: 通过行政核心提供行政服务和支持。将提供CCCR研究和外展工作的财务,程序化和培训方面的支持。 一组互动研究核心的操作。 CCCR调查人员将拥有通过四个核心提供的最先进的专业知识和技术,每个核心都由CCCR教师的经验丰富且知识渊博的成员领导。 监督研究试点项目计划。通过对研究人员开发的启动种子项目的支持以及多学科计划的开发,试点项目工作将使进入挑战的新研究领域,并将调解独特的合作。此外,该项目将管理服务不足少数民族的研究生奖学金计划。 总的来说,包括CCCR的跨学科教师所表现出的广泛的知识和水平为维持III期时期内建立的知识和水平提供了基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FRANKLIN G. BERGER其他文献

FRANKLIN G. BERGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FRANKLIN G. BERGER', 18)}}的其他基金

Center for Colon Cancer Research
结肠癌研究中心
  • 批准号:
    8514828
  • 财政年份:
    2013
  • 资助金额:
    $ 108.22万
  • 项目类别:
Center for Colon Cancer Research
结肠癌研究中心
  • 批准号:
    9116003
  • 财政年份:
    2013
  • 资助金额:
    $ 108.22万
  • 项目类别:
Center for Colon Cancer Research
结肠癌研究中心
  • 批准号:
    9322378
  • 财政年份:
    2013
  • 资助金额:
    $ 108.22万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    8360346
  • 财政年份:
    2011
  • 资助金额:
    $ 108.22万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    8167866
  • 财政年份:
    2010
  • 资助金额:
    $ 108.22万
  • 项目类别:
PREDICTING THE RESPONSE TO TREATMENT USING GENE MUTATION PROFILING
使用基因突变分析预测治疗反应
  • 批准号:
    7960645
  • 财政年份:
    2009
  • 资助金额:
    $ 108.22万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    7959754
  • 财政年份:
    2009
  • 资助金额:
    $ 108.22万
  • 项目类别:
Center for Colon Cancer Research
结肠癌研究中心
  • 批准号:
    7898077
  • 财政年份:
    2009
  • 资助金额:
    $ 108.22万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    7720807
  • 财政年份:
    2008
  • 资助金额:
    $ 108.22万
  • 项目类别:
ADMINISTRATIVE CORE
行政核心
  • 批准号:
    7610465
  • 财政年份:
    2007
  • 资助金额:
    $ 108.22万
  • 项目类别:

相似海外基金

Addressing Surgical Disparities at the Root; Working to improve diversity in the surgical workforce
从根本上解决手术差异;
  • 批准号:
    10639471
  • 财政年份:
    2023
  • 资助金额:
    $ 108.22万
  • 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
  • 批准号:
    10855627
  • 财政年份:
    2023
  • 资助金额:
    $ 108.22万
  • 项目类别:
NIDA Clinical Trials Network: New York Node - GY22 Integrating MOUD in Non-Medical Settings to Improve Treatment and Retention of Black/AA Persons
NIDA 临床试验网络:纽约节点 - GY22 在非医疗环境中整合 MOUD,以改善黑人/AA 人的治疗和保留
  • 批准号:
    10809985
  • 财政年份:
    2023
  • 资助金额:
    $ 108.22万
  • 项目类别:
A Translational Research Approach to Healthy Technology Usage in Language-Minority Families with Young Children
有幼儿的语言少数群体家庭健康技术使用的转化研究方法
  • 批准号:
    10822222
  • 财政年份:
    2023
  • 资助金额:
    $ 108.22万
  • 项目类别:
Developing Extracellular Vesicle Based MPRINT Translational Resource Platform for Monitoring Therapeutics Response During Pregnancy
开发基于细胞外囊泡的 MPRINT 转化资源平台,用于监测妊娠期间的治疗反应
  • 批准号:
    10747545
  • 财政年份:
    2023
  • 资助金额:
    $ 108.22万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了